{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:19:37Z","timestamp":1792279177491,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinre.2025.102680","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:12:34Z","timestamp":1756768354000},"page":"102680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A series of pediatric patients with inflammatory bowel disease switching from intravenous to subcutaneous infliximab maintenance therapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Anne Sophie","family":"Duquerois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Martinez-Vinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Loppinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioara","family":"Restier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Poinsot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Portefaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Heissat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Peretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Duclaux-Loras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2025.102680_bib0001","doi-asserted-by":"crossref","first-page":"1106\u201113","DOI":"10.1053\/j.gastro.2008.06.079","article-title":"Natural history of pediatric Crohn\u2019s disease: a population-based cohort study","volume":"135","author":"Vernier-Massouille","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2025.102680_bib0002","doi-asserted-by":"crossref","first-page":"2080\u20118","DOI":"10.1038\/ajg.2009.177","article-title":"The natural history of pediatric ulcerative colitis: a population-based cohort study","volume":"104","author":"Gower-Rousseau","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2025.102680_bib0003","first-page":"257\u201191","article-title":"Management of Paediatric ulcerative Colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn\u2019s and Colitis organization and European society of paediatric gastroenterology, hepatology and nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2025.102680_bib0004","first-page":"jjaa161","article-title":"The medical management of Paediatric Crohn\u2019s disease: an ECCO-ESPGHAN guideline update","author":"van Rheenen","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2025.102680_bib0005","series-title":"Database Of Abstracts Of Reviews Of Effects (DARE): Quality-Assessed Reviews","article-title":"Anti-TNF-alpha drugs for refractory inflammatory bowel disease: clinical- and cost-effectiveness analyses","author":"Assasi","year":"2009"},{"key":"10.1016\/j.clinre.2025.102680_bib0006","doi-asserted-by":"crossref","first-page":"2340\u201153","DOI":"10.1053\/j.gastro.2021.02.068","article-title":"Randomized controlled trial: subcutaneous vs intravenous Infliximab CT-P13 maintenance in inflammatory bowel disease","volume":"160","author":"Schreiber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2025.102680_bib0007","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.cgh.2022.08.011","article-title":"Effectiveness of switching from intravenous to subcutaneous Infliximab in patients with inflammatory bowel diseases: the REMSWITCH study","volume":"21","author":"Buisson","year":"2023","journal-title":"Clin Gastroenterol Hepatol Clin Pr J Am Gastroenterol Assoc"},{"key":"10.1016\/j.clinre.2025.102680_bib0008","doi-asserted-by":"crossref","DOI":"10.2196\/13888","article-title":"Identifying health economic considerations to include in the research protocol of a randomized controlled trial (the REDUCE-RISK Trial): systematic literature review and assessment","volume":"5","author":"Neyt","year":"2021","journal-title":"JMIR Form Res"},{"key":"10.1016\/j.clinre.2025.102680_bib0009","first-page":"121\u201139","article-title":"Adalimumab: a review of its use in rheumatoid arthritis","volume":"18","author":"Bang","year":"2004","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"key":"10.1016\/j.clinre.2025.102680_bib0010","doi-asserted-by":"crossref","first-page":"953\u201161","DOI":"10.1002\/ibd.21152","article-title":"Natural history of Crohn\u2019s disease: comparison between childhood- and adult-onset disease","volume":"16","author":"Pigneur","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2025.102680_bib0011","doi-asserted-by":"crossref","first-page":"235\u20119","DOI":"10.1097\/MPG.0000000000003838","article-title":"Effectiveness of switching to subcutaneous Infliximab in pediatric inflammatory bowel disease patients on intravenous maintenance therapy","volume":"77","author":"Gianolio","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2025.102680_bib0012","doi-asserted-by":"crossref","first-page":"1440\u20119","DOI":"10.1093\/ecco-jcc\/jjae059","article-title":"Intravenous versus subcutaneous Infliximab in inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Chetwood","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2025.102680_bib0013","doi-asserted-by":"crossref","first-page":"1436\u201146","DOI":"10.1093\/ecco-jcc\/jjac053","article-title":"Efficacy and safety of elective switching from intravenous to subcutaneous Infliximab [CT-P13]: a multicentre cohort study","volume":"16","author":"Smith","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2025.102680_bib0014","doi-asserted-by":"crossref","first-page":"1935\u201144","DOI":"10.1007\/s00431-020-03750-0","article-title":"Infliximab in young paediatric IBD patients: it is all about the dosing","volume":"179","author":"Jongsma","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clinre.2025.102680_bib0015","first-page":"553","article-title":"P0472 Switching from intravenous to subcutaneous infliximab in patients with active inflammatory bowel disease: post-hoc analysis of pre\/post switch outcomes from a multicentre, randomised controlled pivotal trial. Abstract and poster presented at UEGW","volume":"9","author":"Schreiber","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.clinre.2025.102680_bib0016","doi-asserted-by":"crossref","first-page":"S11\u20112","DOI":"10.1053\/j.gastro.2023.11.051","article-title":"Efficacy, safety and immunogenicity of subcutaneous infliximab (ct-p13 sc) monotherapy versus combination therapy with immunosuppressants \u2013 post hoc analysis of liberty-cd and liberty-uc study","volume":"166","author":"Schreiber","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2025.102680_bib0017","doi-asserted-by":"crossref","first-page":"277\u201188","DOI":"10.1007\/s40261-023-01252-z","article-title":"Subcutaneous infliximab monotherapy versus combination therapy with immunosuppressants in inflammatory bowel disease: a post hoc analysis of a randomised clinical trial","volume":"43","author":"D\u2019Haens","year":"2023","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinre.2025.102680_bib0018","doi-asserted-by":"crossref","first-page":"i1836","DOI":"10.1093\/ecco-jcc\/jjad212.1151","article-title":"P1021 Comparison of subcutaneous and intravenous infliximab in patients with inflammatory bowel disease showed no differences in immunogenicity or treatment persistence at one year","volume":"18","author":"Hancox","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2025.102680_bib0019","first-page":"S1542","article-title":"Immunogenicity and efficacy of Subcutaneous infliximab monotherapy vs combination therapy in inflammatory bowel disease: a systematic review and meta-analysis","author":"Anjie","year":"2025","journal-title":"Clin Gastroenterol Hepatol Clin Pr J Am Gastroenterol Assoc"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:35:36Z","timestamp":1759548936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125001573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2210740125001573"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102680","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A series of pediatric patients with inflammatory bowel disease switching from intravenous to subcutaneous infliximab maintenance therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102680"}}